BST News and Press, BlackRock Science and Technology Trust of Beneficial Interest From 02/09/22

I update my past lists of my top ten monthly payers, which I began compiling in 2015. I rank monthly payers by total return and dependability. The list has a number of new additions, though the old stalwarts remain. For further details see: My Top Ten Monthly Payers

BST NAV has dropped significantly since late last year. I continue my series digging into CEFs beyond the yield with another look at BST. The share price has been falling, so the yield is up. Long term the distribution is still covered, so this price drop is an opportunity. ...

BST and BSTZ were two popular tech fund darlings, with recent losses investors are rightfully concerned. The two funds share many similarities, but we can also see the differences once you dig a bit deeper. Both funds provide attractive distribution yields that I believe will be m...

This article reviews my portfolio of dividend growth stocks, DivGro. I summarize transactions and show how those transactions affect DivGro's projected annual dividend income. I opened two new positions in November and added shares to 17 existing positions. Additionally, I reduced the...

CEFs may be more susceptible to tax loss selling given they trade on a stock exchange and market prices (investor return) can deviate from underlying NAVs (fund return). Additionally, CEFs typically provide income to shareholders through monthly distributions. These dynamics may creat...

For income investors, closed-end funds remain an attractive investment class that covers a variety of asset classes and promise high distributions and reasonable total returns. Closed-end funds are generally characterized by higher volatility and deeper drawdowns than the broad market...

With 2022 likely to be a wild ride, we income investors are going to lean on two key advantages. In doing so, we’ll secure 7% dividends no matter what the broader markets do. First, we can secure this “head start” by January 1 by purchasing funds that yield 7%, on a...

BME is a closed-end fund managed by BlackRock that utilizes an equity-focused portfolio, supplemented with derivatives, to drive current income and total return. The fund has a current yield of 5.47% and has outperformed the S&P 500 since inception. BME currently trades at an ...

The S&P 500 has not only fully recovered from the lows of the 2020 pandemic but has added on nearly 45% compared to the beginning of 2020. Will the current bull run continue in 2022, or are we heading towards a cliff? Should you invest now or wait for lower prices? We provide ...

Management raised the monthly payouts again in October by ~10%. It's selling a much cheaper NAV discount vs. its historical averages. The article also covers BSTZ, which is also selling at a discount. Management also raised its monthly dividends twice in 2021. We compare BST and B...